Costimulation Blockade Holds Emerging Hope for Patients in Large Markets Only.

Gill, J S; Halloran, P; Jevnikar, T; Cole, E; Rush, D; Knoll, G

Gill, J S; Halloran, P; Jevnikar, T; Cole, E; Rush, D; Knoll, G.

Afiliación

Gill JS; Division of Nephrology, University of British Columbia, Vancouver, British Columbia, Canada.
Halloran P; Division of Nephrology & Transplant Immunology, Department of Medicine, University of Alberta, Edmonton, Alberta, Canada.
Jevnikar T; Division of Nephrology and Transplantation, Department of Medicine, University of Western Ontario, London, Ontario, Canada.
Cole E; University Health Network, Toronto General Hospital, Toronto, Ontario, Canada.
Rush D; Internal Medicine/Nephrology, Health Sciences Centre, Winnipeg, Manitoba, Canada.
Knoll G; Division of Nephrology, Department of Medicine, Ottawa General Hospital, Ottawa, ON, Canada.

Am J Transplant ; 17(4): 1147, 2017 04.

Article en En | MEDLINE | ID: mdl-28039954

Asunto(s)

Ciclosporina; Donantes de Tejidos; Abatacept; Supervivencia de Injerto; Humanos

Palabras clave

clinical research/practice; economics; immunosuppressant; kidney transplantation/nephrology; other

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Donantes de Tejidos / Ciclosporina Límite: Humans Idioma: En Revista: Am J Transplant Asunto de la revista: TRANSPLANTE Año: 2017 Tipo del documento: Article País de afiliación: Canadá

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google